Human health

Respi+ (FluA/ FluB/ COVID/ RSV)

Kit for the qualitative detection and simultaneous differentiation of influenza A, influenza B, SARS-CoV-2 and RSV RNA.

Influenza virus types identified: Influenza A o Generic o Pandemic H1N1 2009 o Generic H3 Influenza B: Victoria and Yamagata lines o Victoria lines o Yamagata lines 2 Respiratory syncytial virus types detected: A and B. Specific primers and a fluorescent probe are included for simultaneous detection of the human RNaseP gene as an internal quality control for starting and amplification material.
Compatible with all major automated extraction and dispensing systems and real-time PCR machines on the market.

Indication

in vitro diagnostic kit for the simultaneous qualitative detection and differentiation of influenza A virus (FluA), influenza B virus (FluB), SARS-CoV-2 and/or respiratory syncytial virus (RSV) RNA.

Principle

Real-time PCR

Withdrawal

nasopharyngeal, oropharyngeal and bronchoalveolar lavage (BAL) tests

Target sequences

Mp gene (FluA ), gene (FluB), N gene (SARS-CoV-2) and Mp gene (RSV), RNaseP

Detection Limit (LoD)

10 copies/reaction

Specific

– SARS-CoV-2: 100% – Influenza A: 96.96% – Influenza B: 100% – Respiratory Syncytial Virus: 100% – SARS-CoV-2: 100% – Influenza A: 96.96% – Influenza B: 100% – Respiratory Syncytial Virus: 100%.

Sensitivity

– SARS-CoV-2: 100% – Influenza A: 92.37% – Influenza B: 100% – Respiratory syncytial virus: 93.75

Storage (t°C)

-10°C and -30°C

Catalog number

MD0017

Packaging

50 tests

Manufacturer

VITRO – MASTER DIAGNOSTICA

Country

Spain

Ask for a quote

If you have any questions or would like to discuss our services, we invite you to contact us. Our team is always available to assist you, 7 days a week, and is committed to responding to all your requests in less than 24 hours.

Please enable JavaScript in your browser to complete this form.

Related products

Human health

Respi+ (FluA/ FluB/ COVID/ RSV)

Read more

Human health

HybriSpot – Panel on tick-borne infections

Detection kit for major tick-borne pathogens

Read more

Human health

HybriSpot – Respiratory Panel

Detection kit for major pathogens causing acute respiratory infections

Read more

Any questions?

At Respi+ (FluA/ FluB/ COVID/ RSV), we understand the regulatory challenges faced by our French customers. We offer support in your accreditation process, including assistance in preparing the files needed to validate new techniques. Our approach is to provide local support, with flexibility and adaptability.

We are ISO 13485:2016 certified, demonstrating our commitment to the highest international standards for medical devices. What’s more, all our products are designed and manufactured in France, guaranteeing a high level of expertise and quality control.

We maintain a strategic buffer stock for all our distributed products, minimizing the risk of stock-outs. Should the need arise, our Lyon-based after-sales service is ready to react quickly to ensure your business continues uninterrupted.

Our logistics are optimized for rapid delivery throughout France and internationally. With efficient processes and a well-established distribution network, we ensure that your orders reach you in the shortest possible time.